<DOC>
	<DOCNO>NCT00114920</DOCNO>
	<brief_summary>The primary purpose study evaluate effectiveness adult , four different strength resiquimod gel applied common wart ( ) three time week twelve week . A second purpose evaluate safety drug .</brief_summary>
	<brief_title>Twelve Week Safety Efficacy Study With Topical Gel Treat Common Warts Adults</brief_title>
	<detailed_description />
	<mesh_term>Warts</mesh_term>
	<criteria>Diagnosis common wart Two form birth control Pregnant breast feed Other type wart ( ) , ie . plantar Currently participate another clinical study Chronic viral hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Wart ( )</keyword>
	<keyword>Adults</keyword>
	<keyword>Common Wart ( )</keyword>
</DOC>